{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "D-dimer", "IL-6", "Immunoceutical", "Oxygen", "Ozone therapy", "Pneumonia"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32795898", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "23"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "08", "Day": "08"}], "ELocationID": ["10.1016/j.intimp.2020.106879", "S1567-5769(20)31494-6"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "88", "PubDate": {"Year": "2020", "Month": "Nov"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "Oxygen-ozone (O<sub>2</sub>-O<sub>3</sub>) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.", "Pagination": {"StartPage": "106879", "MedlinePgn": "106879"}, "Abstract": {"AbstractText": ["This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O<sub>2</sub>-O<sub>3</sub>) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly COVID-19 patients, particularly when hospitalized in intensive care units (ICUs) Experimental design: We investigated the therapeutic effect of 4 cycles of O<sub>2</sub>-O<sub>3</sub> in 50 hospitalized COVID-19 subjects suffering from acute respiratory disease syndrome (ARDS), aged more than 60\u00a0years, all males and undergoing non invasive mechanical ventilation in ICUs.", "Following O<sub>2</sub>-O<sub>3</sub> treatment a significant improvement in inflammation and oxygenation indexes occurred rapidly and within the first 9\u00a0days after the treatment, despite the expected 14-20\u00a0days. A significant reduction of inflammatory and thromboembolic markers (CRP, IL-6, D-dimer) was observed. Furthermore, amelioration in the major respiratory indexes, such as respiratory and gas exchange markers (SatO<sub>2</sub>%, PaO<sub>2</sub>/FiO<sub>2</sub> ratio), was reported.", "Our results show that O<sub>2</sub>-O<sub>3</sub> treatment would be a promising therapy for COVID-19 patients. It leads patients to a fast recovery from ARDS via the improvement of major respiratory indexes and blood gas parameters, following a relatively short time of dispensed forced ventilation (about one to two weeks). This study may encourage the scientific community to further investigate and evaluate the proposed method for the treatment of COVID-19 patients."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SIOOT, High School in Oxygen Ozone Therapy, University of Pavia, Italy; SIOOT INTERNATIONAL, Communian Clinic, Gorle Bergamo, Italy."}], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SIOOT, High School in Oxygen Ozone Therapy, University of Pavia, Italy; SIOOT INTERNATIONAL, Communian Clinic, Gorle Bergamo, Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Science, University of Pavia, Italy."}], "LastName": "Ricevuti", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Electronic address: salvatore.chirumbolo@univr.it."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Venlo University B.V., Venlo, Netherlands."}], "LastName": "Depfenhart", "ForeName": "Markus", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Dentistry, Paediatrics and Gynaecology Unit of Maxillo-Facial Surgery, University of Verona, Verona, Italy."}], "LastName": "Bertossi", "ForeName": "Dario", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SIOOT INTERNATIONAL, Communian Clinic, Gorle Bergamo, Italy; Department of Drug Science, University of Pavia, Italy."}], "LastName": "Tirelli", "ForeName": "Umberto", "Initials": "U"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "Blood Gas Analysis"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["instrumentation", "methods"], "DescriptorName": "Immunotherapy"}, {"QualifierName": [], "DescriptorName": "Infusions, Intravenous"}, {"QualifierName": [], "DescriptorName": "Intensive Care Units"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Oxygen"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "Respiration, Artificial"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Respiratory Distress Syndrome"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li T., Lu H., Zhang W. Clinical observation and management of COVID-19 patients. Emerg. Microbes Infect. 2020;9(1):687\u2013690.", "ArticleIdList": ["PMC7103696", "32208840"]}, {"Citation": "Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R., Azman A.S., Reich N.G., Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann. Intern. Med. 2020;172(9):577\u2013582.", "ArticleIdList": ["PMC7081172", "32150748"]}, {"Citation": "Wu D., Wu T., Liu Q., Yang Z. The SARS-CoV-2 outbreak: What we know [published online ahead of print, 2020 Mar 12] Int. J. Infect. Dis. 2020;94:44\u201348.", "ArticleIdList": ["PMC7102543", "32171952"]}, {"Citation": "Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., Trilling M., Lu M., Dittmer U., Yang D. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS\u2010CoV, MERS\u2010CoV, and 2019\u2010nCoV. J Med Virol. 2020;92(5):491\u2013494.", "ArticleIdList": ["PMC7166760", "32056249"]}, {"Citation": "Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846\u2013848.", "ArticleIdList": ["PMC7080116", "32125452"]}, {"Citation": "Sorbello M., El\u2010Boghdadly K., Di Giacinto I., Cataldo R., Esposito C., Falcetta S., Merli G., Cortese G., Corso R.M., Bressan F., Pintaudi S., Greif R., Donati A., Petrini F. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020;75(6):724\u2013732.", "ArticleIdList": ["32221973"]}, {"Citation": "Phimister E.G., Hotchkiss R.S., Opal S.M. Activating Immunity to Fight a Foe \u2014 A New Path. N Engl J Med. 2020;382(13):1270\u20131272.", "ArticleIdList": ["PMC8025910", "32212525"]}, {"Citation": "Valdenassi L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C., Tirelli U. Potential mechanisms by which the oxygen-ozone (O2\u2013O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(8):4059\u20134061.", "ArticleIdList": ["32374009"]}, {"Citation": "S. Chirumbolo, G. Bj\u00f8rklund. The bimodal SARS-CoV2 as an effect of environmental and allergic causes J Allergy Clin Immunology 2020 in press, DOI:https://doi.org/10.1016/j.jaci.2020.05.011.", "ArticleIdList": ["PMC7253996", "32507495"]}, {"Citation": "Hern\u00e1ndez A., Papadakos P.J., Torres A. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19 [published online ahead of print, 2020 Apr 14]. Dos terapias conocidas podr\u00edan ser efectivas como adyuvantes en el paciente critic infectado por COVID-19 [published online ahead of print, 2020 Apr 14] Rev. Esp. Anestesiol Reanim. 2020;S0034\u20139356(20):30075-X. doi: 10.1016/j.redar.2020.03.004.", "ArticleIdList": ["10.1016/j.redar.2020.03.004", "PMC7156242", "32303365"]}, {"Citation": "A., Hernandez, V., Montserrat, A., Pablos, F., Vlas, P., J., Papadokos, D., N., Wijeeysundera, M., Vives. Ozone therapy for patients with SARS-CoV2 pneumonia: a single-center prospective cohort study MedRXiv doi: https://doi.org/10.1101/2020.06.03.20117994, June 12, 2020."}, {"Citation": "Pourhoseingholi M.A., Vahedi M., Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol. Hepatol. Bed. Bench. 2013;6(1):14\u201317.", "ArticleIdList": ["PMC4017493", "24834239"]}, {"Citation": "Lan P.T., Cuong H.Q., Linh H.T., Hieu N.T., Anh N.H., Ton T., Dong T.C., Thao V.T., Tuoi D.T.H., Tuan N.D., Kim Loan H.T., Long N.T., Thang C.M., Hai N.D., Thao N.T.T. Development of standardized specimens with known concentrations for severe acute respiratory syndrome coronavirus 2 Realtime-RT-PCR testing validation. Bull. World Health Organ. E-pub. April 2020;20 doi: 10.2471/BLT.20.259630. [Preprint]", "ArticleIdList": ["10.2471/BLT.20.259630"]}, {"Citation": "Marfella R., Paolisso P., Sardu C., Bergamaschi L., D\u2019Angelo E.C., Barbieri M., Rizzo M.R., Messina V., Maggi P., Coppola N., Pizzi C., Biffi M., Viale P., Gali\u00e8 N., Paolisso G. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients [published online ahead of print, 2020 May 21]. Diabetes Metab. S1262. 2020;3636(20):30082\u201330083. doi: 10.1016/j.diabet.2020.05.005.", "ArticleIdList": ["10.1016/j.diabet.2020.05.005", "PMC7241396", "32447102"]}, {"Citation": "Ahn D.G., Shin H.J., Kim M.H. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) J. Microbiol. Biotechnol. 2020;30(3):313\u2013324.", "ArticleIdList": ["PMC9728410", "32238757"]}, {"Citation": "Elvis A.M., Ekta J.S. Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2011;2(1):66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "V., Simonetti, V., Quagliariello, M., Franzini, R.V., Iaffaioli, N., Maurea, L., Valdenassi. Ozone Exerts Cytoprotective and Anti-Inflammatory Effects in Cardiomyocytes and Skin Fibroblasts after Incubation with Doxorubicin. Evid Based Complement Alternat Med. 2019 (2019) 2169103. Published 2019 Nov 18. doi:10.1155/2019/2169103H.", "ArticleIdList": ["PMC6885772", "31827546"]}, {"Citation": "Zhang J.M., Penninger Y., Li N., Zhong A.S., Slutsky Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potentialtherapeutic target. Intensive Care Med. 2020;46(4):586\u2013590.", "ArticleIdList": ["PMC7079879", "32125455"]}, {"Citation": "Han H., Yang L., Liu R. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [published online ahead of print, 2020 Mar 16] Clin. Chem. LabMed. 2020 doi: 10.1515/cclm-2020-0188. /j/cclm.ahead-of-print/cclm-2020-0188/cclm-2020-0188.xml.", "ArticleIdList": ["10.1515/cclm-2020-0188", "32172226"]}, {"Citation": "Kahle J.I., Neas L.M., Devlin R.B. Interaction effects of temperature and ozone on lung function and markers of systemic inflammation, coagulation, and fibrinolysis: a crossover study of healthy young volunteers. Environ Health Perspect. 2015;123(4):310\u2013316. doi: 10.1289/ehp.1307986.", "ArticleIdList": ["10.1289/ehp.1307986", "PMC4384199", "25514459"]}, {"Citation": "Akerstr\u00f6m S., Gunalan V., Keng C.T., Tan Y.J., Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the Sprotein are affected. Virology. 2009;395(1):1\u20139.", "ArticleIdList": ["PMC7111989", "19800091"]}, {"Citation": "Robba C., Robba C., Battaglini D., Ball L., Patroniti L.N., Loconte M., Brunetti I., Vena A., Giacobbe D., Bassetti M., Rocco P.R.M., Pelosi P. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19, Respiratory Physiology and amp. Neurobiology. 2020 doi: 10.1016/j.resp.2020.103455.", "ArticleIdList": ["10.1016/j.resp.2020.103455", "PMC7211757", "32437877"]}, {"Citation": "Punjabi C.J., Laskin J.D., Pendino K.J., Goller N.L., Durham S.K., Laskin D.L. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol. 1994;11(2):165\u2013172.", "ArticleIdList": ["7519435"]}, {"Citation": "Rowen R.J. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019;9(4):232\u2013237.", "ArticleIdList": ["PMC7802416", "31898609"]}, {"Citation": "Sagai M., Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healinginduced via a mild oxidative stress? Med Gas Res. 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "S. Safari, M. Mehrani, M. Yousefifard. Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary. Arch AcadEmerg Med. 8(1) (2020) e52. Published 2020 Apr 19.", "ArticleIdList": ["PMC7212069", "32440663"]}, {"Citation": "Deng L., Meng W., Li D., Qiu D., Wang S., Liu H. The effect of ozone on hypoxia, hemolysis and morphological change of blood from patients with aortic dissection (AD): a preliminary in vitro experiment of ozonated autohemotherapy for treating AD. Am. J. Transl. Res. 2018;10(6):1829\u20131840. Published 2018 Jun 15.", "ArticleIdList": ["PMC6038082", "30018723"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "9"}, {"Year": "2020", "Month": "8", "Day": "4"}, {"Year": "2020", "Month": "8", "Day": "4"}, {"Year": "2020", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32795898", "PMC7414302", "10.1016/j.intimp.2020.106879", "S1567-5769(20)31494-6"]}}], "PubmedBookArticle": []}